Lifecore Biomedical (LFCR) Total Debt: 2010-2025
Historic Total Debt for Lifecore Biomedical (LFCR) over the last 15 years, with May 2025 value amounting to $121.2 million.
- Lifecore Biomedical's Total Debt rose 19.30% to $121.2 million in Q2 2025 from the same period last year, while for May 2025 it was $121.2 million, marking a year-over-year increase of 19.30%. This contributed to the annual value of $121.2 million for FY2025, which is 19.30% up from last year.
- Per Lifecore Biomedical's latest filing, its Total Debt stood at $121.2 million for Q2 2025, which was up 4.79% from $115.7 million recorded in Q1 2025.
- Over the past 5 years, Lifecore Biomedical's Total Debt peaked at $193.9 million during Q2 2021, and registered a low of $84.8 million during Q2 2023.
- Its 3-year average for Total Debt is $101.9 million, with a median of $100.2 million in 2023.
- Its Total Debt has fluctuated over the past 5 years, first slumped by 49.37% in 2022, then climbed by 19.86% in 2024.
- Lifecore Biomedical's Total Debt (Quarterly) stood at $166.2 million in 2021, then slumped by 40.46% to $99.0 million in 2022, then dropped by 6.16% to $92.9 million in 2023, then climbed by 19.86% to $111.3 million in 2024, then rose by 19.30% to $121.2 million in 2025.
- Its Total Debt was $121.2 million in Q2 2025, compared to $115.7 million in Q1 2025 and $111.3 million in Q4 2024.